Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD99 regulates normal and malignant stem cell function by restricting protein translation
    Meeting Abstract

    Chung, S. S.; Hu, W.; Guo, L.; Kannan, L.; Levine, R. L.; Park, C. Y.
    Blood (2017)

    Fulltext@MSK | Save
  • Targeted deep sequencing in untreated progressive CLL helps to better dissect the genomic landscape and shows novel associations between mutations, prognostic and clinical parameters: Data from E1912, a randomized phase III study of the ECOG-ACRIN cancer research group
    Meeting Abstract

    Braggio, E.; Wang, V.; Bruins, L. A.; Barrio, S.; Lesnick, C.; Barrientos, J. C.; O'Brien, S. M.; Tallman, M. S.; Litzow, M. R.; Fonseca, R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Changes in RT-qPCR levels during and after TKI interruptions for attempted conceptions in women with CML
    Meeting Abstract

    Caldwell, L.; Claudiani, S.; Milojkovic, D.; Szydlo, R.; Abruzzese, E.; Nesr, G.; Mauro, M. J.; Palanicawander, R.; Gatenby, A.; Sabli, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • National survey demonstrates practice gaps in cytogenetic and molecular testing in acute myeloid leukemia
    Meeting Abstract

    Altman, J. K.; Denzen, E.; Block, A. W.; Hasserjian, R. P.; Klepin, H.; Medeiros, B. C.; Noe, A.; Scales, W. E.; Tallman, M. S.; Wiley, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) based IGH and TCR clonality assays provide excellent specificity and sensitivity for routine clonal characterization and monitoring of lymphoproliferative disorders
    Meeting Abstract

    Arcila, M. E.; Syed, M.; Yu, W.; Kim, H.; Yao, J.; Ho, C.; Petrova-Drus, K.; Roshal, M.; Park, J. H.; Landgren, O.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Ivosidenib or enasidenib combined with standard induction chemotherapy is well tolerated and active in patients with newly diagnosed AML with an IDH1 or IDH2 mutation: Initial results from a phase 1 trial
    Meeting Abstract

    Stein, E. M.; DiNardo, C. D.; Mims, A. S.; Savona, M. R.; Pratz, K.; Stein, A. S.; Fathi, A. T.; Stone, R. M.; Pollyea, D. A.; Odenike, O.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: Results of a phase 1 dose escalation and expansion study
    Meeting Abstract

    DiNardo, C. D.; De Botton, S.; Stein, E. M.; Roboz, G. J.; Mims, A. S.; Pollyea, D. A.; Swords, R. T.; Altman, J. K.; Collins, R. H.; Mannis, G. N.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • TET2 in normal and malignant hematopoiesis
    Journal Article

    Bowman, R. L.; Levine, R. L.
    Cold Spring Harbor Perspectives in Medicine (2017)

    Fulltext@MSK | Save
  • Efficacy and safety outcomes by baseline comorbidity and age in patients newly diagnosed with chronic myeloid leukemia in chronic phase (CML-CP) and treated with dasatinib or imatinib in DASISION
    Meeting Abstract

    Mauro, M. J.; Cortes, J. E.; Hochhaus, A.; Shah, N. P.; Atallah, E.; Abaskharoun, M.; Sy, O.; Saglio, G.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Targeting the endosteal niche in myelodysplasia and acute myeloid leukemia
    Meeting Abstract

    Galán-Díez, M.; Bhagat, G.; Teruya-Feldstein, J.; Raza, A.; Berman, E.; Kousteni, S.
    Journal of Bone and Mineral Research (2017)

    Fulltext@MSK | Save